Search

Your search keyword '"Thull, Darcy L."' showing total 155 results

Search Constraints

Start Over You searched for: Author "Thull, Darcy L." Remove constraint Author: "Thull, Darcy L."
155 results on '"Thull, Darcy L."'

Search Results

1. The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant.

3. Polygenic risk modeling for prediction of epithelial ovarian cancer risk

4. Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers

5. Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2

6. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

7. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

8. Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk

9. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

10. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

11. Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores

12. Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores

13. Personalising therapy for early-stage oestrogen receptor-positive breast cancer in older women

14. The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant

15. Author Correction : A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

18. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

19. Transcriptome‐wide association study of breast cancer risk by estrogen‐receptor status

20. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

21. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

24. The FANCM :p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

25. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

27. Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

28. Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

29. Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

30. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

31. Knowledge and opinions regarding BRCA1 and BRCA2 genetic testing among primary care physicians.

32. Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.

33. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

34. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1and BRCA2pathogenic variants

35. Male breast cancer in BRCA1 and BRCA2 mutation carriers:pathology data from the Consortium of Investigators of Modifiers of BRCA1/2

41. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status

42. The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant

43. Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

44. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

45. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

46. Polygenic Risk Modelling for Prediction of Epithelial Ovarian Cancer Risk

47. Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores

48. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

49. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

50. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

Catalog

Books, media, physical & digital resources